191 related articles for article (PubMed ID: 31072635)
1. Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: An analysis of the TOPP registry.
Beghetti M; Brand M; Berger RMF; Humpl T; Wheeler JG; Ivy DD; Bonnet D;
Int J Cardiol; 2019 Aug; 289():110-115. PubMed ID: 31072635
[TBL] [Abstract][Full Text] [Related]
2. [Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease].
Xu ZY; Zhang HS; Li QQ; Zhang C; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):282-288. PubMed ID: 35340148
[No Abstract] [Full Text] [Related]
3. Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry.
Ploegstra MJ; Ivy DD; Beghetti M; Bonnet D; Alehan D; Ablonczy L; Mattos S; Bowers D; Humpl T; Berger RMF;
Eur Heart J Qual Care Clin Outcomes; 2024 Jan; 10(1):66-76. PubMed ID: 36972621
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
Frost AE; Badesch DB; Miller DP; Benza RL; Meltzer LA; McGoon MD
Chest; 2013 Nov; 144(5):1521-1529. PubMed ID: 23907471
[TBL] [Abstract][Full Text] [Related]
5. Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.
Ploegstra MJ; Arjaans S; Zijlstra WMH; Douwes JM; Vissia-Kazemier TR; Roofthooft MTR; Hillege HL; Berger RMF
Chest; 2015 Sep; 148(3):655-666. PubMed ID: 25741884
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
Farber HW; Miller DP; Meltzer LA; McGoon MD
J Heart Lung Transplant; 2013 Nov; 32(11):1114-22. PubMed ID: 24035189
[TBL] [Abstract][Full Text] [Related]
7. Ventricular-vascular coupling is predictive of adverse clinical outcome in paediatric pulmonary arterial hypertension.
Dufva MJ; Ivy D; Campbell K; Lam A; Rauff A; Breeman KTN; Douwes JM; Berger RMF; Kheyfets VO; Hunter K
Open Heart; 2021 Sep; 8(2):. PubMed ID: 34583983
[TBL] [Abstract][Full Text] [Related]
8. Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials.
Blette BS; Moutchia J; Al-Naamani N; Ventetuolo CE; Cheng C; Appleby D; Urbanowicz RJ; Fritz J; Mazurek JA; Li F; Kawut SM; Harhay MO
Lancet Respir Med; 2023 Oct; 11(10):873-882. PubMed ID: 37230098
[TBL] [Abstract][Full Text] [Related]
9. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
[TBL] [Abstract][Full Text] [Related]
11. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
[TBL] [Abstract][Full Text] [Related]
12. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.
Rosenzweig EB; Abman SH; Adatia I; Beghetti M; Bonnet D; Haworth S; Ivy DD; Berger RMF
Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545978
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON Study.
Gaine S; Sitbon O; Channick RN; Chin KM; Sauter R; Galiè N; Hoeper MM; McLaughlin VV; Preiss R; Rubin LJ; Simonneau G; Tapson V; Ghofrani HA; Lang I
Chest; 2021 Jul; 160(1):277-286. PubMed ID: 33545163
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.
Xanthouli P; Koegler M; Marra AM; Benjamin N; Fischer L; Eichstaedt CA; Harutyunova S; Nagel C; Grünig E; Egenlauf B
Respir Res; 2020 May; 21(1):127. PubMed ID: 32448256
[TBL] [Abstract][Full Text] [Related]
15. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
17. Fluid challenge predicts clinical worsening in pulmonary arterial hypertension.
D'Alto M; Motoji Y; Romeo E; Argiento P; Di Marco GM; Mattera Iacono A; D'Andrea A; Rea G; Golino P; Naeije R
Int J Cardiol; 2018 Jun; 261():167-171. PubMed ID: 29559180
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of paediatric pulmonary hypertension: a registry study.
Berger RM; Beghetti M; Humpl T; Raskob GE; Ivy DD; Jing ZC; Bonnet D; Schulze-Neick I; Barst RJ
Lancet; 2012 Feb; 379(9815):537-46. PubMed ID: 22240409
[TBL] [Abstract][Full Text] [Related]
19. Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients.
Simonneau G; Galiè N; Jansa P; Meyer GM; Al-Hiti H; Kusic-Pajic A; Lemarié JC; Hoeper MM; Rubin LJ
Int J Cardiol; 2014 Mar; 172(2):332-9. PubMed ID: 24525158
[TBL] [Abstract][Full Text] [Related]
20. Early decline in six-minute walk distance from the time of diagnosis predicts clinical worsening in pulmonary arterial hypertension.
Huang J; Mehta S; Mura M
Respiration; 2015; 89(5):365-73. PubMed ID: 25791910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
